Taiwan FDA: No need to hoard rapid COVID-19 tests, ample supply available

Concerns about shortages of rapid COVID-19 test kits in Taiwan have been addressed by the Food and Drug Administration (FDA). The agency stated on Tuesday that domestic supply remains stable, with approximately 730,000 test kits currently in stock. This includes 610,000 kits at manufacturing sites and 120,000 at retail outlets.

“

Currently, major convenience stores, supermarkets, chain pharmacies, and chain medical equipment channels are maintaining stable supply.

The FDA has ensured that major convenience stores, supermarkets, chain pharmacies, and medical equipment retailers are consistently supplied. To help consumers find available kits, the agency maintains an online "Home Use New Coronavirus Test Kit Supply Information Zone" on its official website. This resource lists over 10,000 retail locations across Taiwan, covering about 80% of the market, and is continuously updated.

“

The current supply volume is higher than the estimated demand and can fully meet the domestic epidemic prevention needs.

Officials estimate that between 330,000 and 590,000 test kits will be needed for the current wave of infections. The current supply exceeds this projected demand, ensuring sufficient availability for public health needs. The FDA also reminded the public to continue practicing personal hygiene and preventive measures. Individuals experiencing suspected COVID-19 symptoms, especially those at high risk, should seek medical attention promptly to reduce the risk of severe illness.

“

There is no need to hoard rapid test kits due to the epidemic. Purchase according to actual needs.